Lakewood Amedex Inc is a privately held biotechnology company developing a diverse portfolio of targeted therapeutics, broad spectrum anti-bacterials, and anti-viral compounds. The Company believes it is well positioned to capitalize on the rising demand for novel therapeutics to combat the increased health risks posed by antibiotic resistant bacteria, emerging viral diseases such as avian influenza, and food borne illness. Collectively, anti-infectives worldwide represent a market in excess of $50 billion with anti-bacterials representing the largest single class generating over $30 billion in sales. Therefore, Lakewood Amedex believes it product portfolio has the potential to produce several blockbuster therapeutics with annual sales in excess of $1 billion.
For more information, please contact:
Lakewood Amedex Inc
9031 Town Center Parkway
Lakewood Ranch, FL 34202
TEL: 941-225-2515
FAX:941-225-2511
or
email: investor@lakewoodamedex.com
|
|